139 results
Page 2 of 7
8-K
EX-99.1
khy oonghymbl7tacagm
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.6
0acpk9x ve
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.5
ns6pfi 405ifzv
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.1
1otlx1
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
424B3
7xu9gpaw8 n9i1f9t75
12 Feb 21
Prospectus supplement
9:43pm
424B3
1g0ve2fxcrxix
8 Feb 21
Prospectus supplement
4:55pm
S-4/A
EX-10.44
mdn9t tsc3ha
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
a8ps9p2o96hezb8 yld
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
8-K
EX-10.2
5wqesm3q45odt
1 Feb 21
Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
5:24pm
8-K
EX-10.1
3fkup
1 Feb 21
Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
5:24pm
424B5
syzxadh
2 Dec 20
Prospectus supplement for primary offering
9:56pm
8-K
EX-1.1
zxaq7uvp6o59f
2 Dec 20
Entry into a Material Definitive Agreement
9:54pm
8-K
EX-1.1
tz0 4obbhusklnfmhmm
2 Nov 20
Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
4:26pm
425
EX-1.1
se2jeuusdws9u0lez15
2 Nov 20
Business combination disclosure
4:24pm
424B5
4093x 3z4l
29 Oct 20
Prospectus supplement for primary offering
5:24pm
424B5
nkfb bm4flyc
28 Oct 20
Prospectus supplement for primary offering
5:25pm
S-4
0pt1p3zu
16 Oct 20
Registration of securities issued in business combination transactions
11:38am